{{cart_num}}
My CartCAS：321914-26-5
Molecular Formula：C47H77N17O16
Molecular Weight：1136.22
Purity：≥95%
Appearance：Lyophilized powder
Storage：Store at -20℃，2 years.(Avoid freeze/thaw cycles)
Qty：
Size：
| Product Type | Peptides |
| CAS | 321914-26-5 |
| Sequence(1LC) | YEQLRNSRA |
| Sequence(3LC) | Tyr-Glu-Gln-Leu-Arg-Asn-Ser-Arg-Ala |
| Molecular Formula | C47H77N17O16 |
| Molecular Weight | 1136.22 |
| Purity | ≥95% |
| Appearance | Lyophilized powder |
| Salt Form | Trifluoroacetate salt |
| Source | Synthetic |
| Storage | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| Category/Label | Other Peptides |
| Background | YEQLRNSRA is a MycC Peptide. MycC Peptide is encoded by c-myc proto-oncogene， the c-myc oncogene has been implicated in malignant progression in a variety of human tumors. MycC Peptide regulates fundamental cellular processes like growth control， metabolism， proliferation， differentiation， and apoptosis. |
| Reference | [1]. McLachlin DT， Chait BT. Improved beta-elimination-based affinity purification strategy for enrichment of phosphopeptides. Anal Chem. 2003 Dec 15;75(24):6826-36. [2]. Hartl M， Bister K. MYC Analysis in Cancer and Evolution. Methods Mol Biol. 2021;2318:87-117. [3]. Garte SJ. The c-myc oncogene in tumor progression. Crit Rev Oncog. 1993;4(4):435-49. PMID: 8353142. |
| Unit | Bottle |
| Specification | 1mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
